肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2016 日本专家共识：肿瘤消融治疗中的消融协议和辅助程序

2016-07-23 日本放射学会 Jpn J Radiol. 2016 Jul 23.

肿瘤消融治疗

2016年7月，日本放射学会(JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药物治疗，围术期疼痛管理，动脉栓塞结合消融治疗，非目标器官的保护，射频消融和冷冻消融协议和消融目标

中文标题：

2016 日本专家共识：肿瘤消融治疗中的消融协议和辅助程序

英文标题：

Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts.

发布机构：

日本放射学会

发布日期：

2016-07-23

简要介绍：

2016年7月，日本放射学会(JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药物治疗，围术期疼痛管理，动脉栓塞结合消融治疗，非目标器官的保护，射频消融和冷冻消融协议和消融目标。


相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 日本专家共识：肿瘤消融治疗中的消融协议和辅助程序)] GetToolGuiderByIdResponse(projectId=1, id=8d6821c0012528d6, title=2016 日本专家共识：肿瘤消融治疗中的消融协议和辅助程序, enTitle=Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts., guiderFrom=Jpn J Radiol. 2016 Jul 23., authorId=null, author=, summary=2016年7月，日本放射学会(JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药物治疗，围术期疼痛管理，动脉栓塞结合消融治疗，非目标器官的保护，射频消融和冷冻消融协议和消融目标, cover=, journalId=null, articlesId=null, associationId=1232, associationName=日本放射学会, associationIntro=, copyright=0, guiderPublishedTime=Sat Jul 23 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年7月，日本放射学会(JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药物治疗，围术期疼痛管理，动脉栓塞结合消融治疗，非目标器官的保护，射频消融和冷冻消融协议和消融目标。 <div><br></div><div> 拓展指南：<strong>与<font color="red">消融治疗</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=d70b31c001069e56" title="热消融治疗原发性和转移性肺部肿瘤的专家共识（2014年版）" target="_blank">热消融治疗原发性和转移性肺部肿瘤的专家共识（2014年版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2a6981c000918eed" title="2013 经皮肝脏肿瘤射频消融治疗操作规范专家共识" target="_blank">2013 经皮肝脏肿瘤射频消融治疗操作规范专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f50701c000808063" title="2011原发性肝癌局部消融治疗的专家共识" target="_blank">2011原发性肝癌局部消融治疗的专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4f9cc1c00080ead8" title="2011 CSLC/CSCO/CMA肝癌射频消融治疗规范的专家共识" target="_blank">2011 CSLC/CSCO/CMA肝癌射频消融治疗规范的专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1b1071c000e5365a" title="2010NICE 英国射频消融治疗Barrett食管指南" target="_blank">2010NICE 英国射频消融治疗Barrett食管指南</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E6%B6%88%E8%9E%8D%E6%B2%BB%E7%96%97" target="_blank">有关消融治疗更多指南</a></ul></div>, tagList=[TagDto(tagId=37211, tagName=肿瘤消融治疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3545, appHits=71, showAppHits=0, pcHits=2826, showPcHits=1032, likes=157, shares=1, comments=4, approvalStatus=1, publishedTime=Wed Aug 10 10:25:27 CST 2016, publishedTimeString=2016-07-23, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Wed Aug 10 10:25:27 CST 2016, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 11:02:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 日本专家共识：肿瘤消融治疗中的消融协议和辅助程序)])
2016 日本专家共识：肿瘤消融治疗中的消融协议和辅助程序
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=99996, encodeId=f7ae99996d8, content=(JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Wed Aug 17 20:44:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99975, encodeId=9ac8999e511, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99976, encodeId=4293999e66e, content=值得收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99974, encodeId=6807999e4e2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:00:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 x35042875

    (JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=99996, encodeId=f7ae99996d8, content=(JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Wed Aug 17 20:44:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99975, encodeId=9ac8999e511, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99976, encodeId=4293999e66e, content=值得收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99974, encodeId=6807999e4e2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:00:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=99996, encodeId=f7ae99996d8, content=(JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Wed Aug 17 20:44:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99975, encodeId=9ac8999e511, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99976, encodeId=4293999e66e, content=值得收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99974, encodeId=6807999e4e2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:00:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    值得收藏

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=99996, encodeId=f7ae99996d8, content=(JRS)发布了关于肿瘤消融治疗中的消融协议和辅助程序的专家共识，该共识主要涉及了6个主题，包括：抗血小板和抗凝管理的药, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Wed Aug 17 20:44:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99975, encodeId=9ac8999e511, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99976, encodeId=4293999e66e, content=值得收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99974, encodeId=6807999e4e2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:00:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续学习

    0